PROM1 and breast neoplasm: We previously demonstrated that PLC-β2, induced by ATRA in APL-derived cells [30], is down-modulated by low oxygen availability in invasive breast tumor derived cells and that its forced expression reduced the levels of CD133 independently on cell phenotype [21, 23].